Ritonavir-free oral 3C-like protease inhibition against COVID-19: a real-world verdict still waiting for its causal trial

Guangqiao Zeng

Open source

DOI: 10.21037/jtd-20262-19
Published: 2026-10
Container: Journal of Thoracic Disease
Publisher: AME Publishing Company
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21037/jtd-20262-19,
  title = {Ritonavir-free oral 3C-like protease inhibition against COVID-19: a real-world verdict still waiting for its causal trial},
  author = {Guangqiao Zeng},
  year = {2026},
  journal = {Journal of Thoracic Disease},
  doi = {10.21037/jtd-20262-19},
  url = {https://doi.org/10.21037/jtd-20262-19}
}

RIS

TY  - JOUR
TI  - Ritonavir-free oral 3C-like protease inhibition against COVID-19: a real-world verdict still waiting for its causal trial
AU  - Guangqiao Zeng
PY  - 2026
JO  - Journal of Thoracic Disease
DO  - 10.21037/jtd-20262-19
UR  - https://doi.org/10.21037/jtd-20262-19
ER  -

APA

Zeng, G. (2026). Ritonavir-free oral 3C-like protease inhibition against COVID-19: a real-world verdict still waiting for its causal trial. Journal of Thoracic Disease. https://doi.org/10.21037/jtd-20262-19

Source records

crossref · retrieved 2026-11-09T16:30:02.106Z